Selected research
Industry Research
Bio Active Protein and Peptides Industry Research Report 2026
Market perspective
The global Bio Active Protein and Peptides market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bio Active Protein and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bio Active Protein and Peptides is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bio Active Protein and Peptides is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bio Active Protein and Peptides include Archer Daniels Midland Company, Kerry Group, Cargill, Omega Protein Corporation, Bunge, DuPont, Fonterra Co-operative Group and Royal DSM, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bio Active Protein and Peptides market in terms of revenue (US$ million) and, where applicable, sales volume (kt), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kt) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bio Active Protein and Peptides Market by Company
Archer Daniels Midland Company
Kerry Group
Cargill
Omega Protein Corporation
Bunge
DuPont
Fonterra Co-operative Group
Royal DSM
Bio Active Protein and Peptides Segment by Type
Plant Source
Animal Source
Bio Active Protein and Peptides Segment by Application
Functional Food
Functional Beverages
Dietary Supplements
Animal Nutrition
Personal Care
Others
Bio Active Protein and Peptides Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio Active Protein and Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bio Active Protein and Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio Active Protein and Peptides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bio Active Protein and Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bio Active Protein and Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bio Active Protein and Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plant Source
- Animal Source
Applications
- Functional Food
- Functional Beverages
- Dietary Supplements
- Animal Nutrition
- Personal Care
- Others
Companies covered
- Archer Daniels Midland Company
- Kerry Group
- Cargill
- Omega Protein Corporation
- Bunge
- DuPont
- Fonterra Co-operative Group
- Royal DSM
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bio Active Protein and Peptides Market Size (2021-2032)
- 2.2.2 Global Bio Active Protein and Peptides Sales (2021-2032)
- 2.2.3 Global Bio Active Protein and Peptides Market Average Price (2021-2032)
- 2.3 Bio Active Protein and Peptides by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Plant Source
- 2.3.3 Animal Source
- 2.4 Bio Active Protein and Peptides by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Functional Food
- 2.4.3 Functional Beverages
- 2.4.4 Dietary Supplements
- 2.4.5 Animal Nutrition
- 2.4.6 Personal Care
- 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bio Active Protein and Peptides Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bio Active Protein and Peptides Sales (kt) of Manufacturers (2021-2026)
- 3.3 Global Bio Active Protein and Peptides Revenue of Manufacturers (2021-2026)
- 3.4 Global Bio Active Protein and Peptides Average Price by Manufacturers (2021-2026)
- 3.5 Global Bio Active Protein and Peptides Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bio Active Protein and Peptides, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bio Active Protein and Peptides, Product Type & Application
- 3.8 Global Manufacturers of Bio Active Protein and Peptides, Established Date
- 3.9 Global Bio Active Protein and Peptides Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Archer Daniels Midland Company
- 4.1.1 Archer Daniels Midland Company Company Information
- 4.1.2 Archer Daniels Midland Company Business Overview
- 4.1.3 Archer Daniels Midland Company Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Archer Daniels Midland Company Bio Active Protein and Peptides Product Portfolio
- 4.1.5 Archer Daniels Midland Company Recent Developments
- 4.2 Kerry Group
- 4.2.1 Kerry Group Company Information
- 4.2.2 Kerry Group Business Overview
- 4.2.3 Kerry Group Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kerry Group Bio Active Protein and Peptides Product Portfolio
- 4.2.5 Kerry Group Recent Developments
- 4.3 Cargill
- 4.3.1 Cargill Company Information
- 4.3.2 Cargill Business Overview
- 4.3.3 Cargill Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cargill Bio Active Protein and Peptides Product Portfolio
- 4.3.5 Cargill Recent Developments
- 4.4 Omega Protein Corporation
- 4.4.1 Omega Protein Corporation Company Information
- 4.4.2 Omega Protein Corporation Business Overview
- 4.4.3 Omega Protein Corporation Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Omega Protein Corporation Bio Active Protein and Peptides Product Portfolio
- 4.4.5 Omega Protein Corporation Recent Developments
- 4.5 Bunge
- 4.5.1 Bunge Company Information
- 4.5.2 Bunge Business Overview
- 4.5.3 Bunge Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bunge Bio Active Protein and Peptides Product Portfolio
- 4.5.5 Bunge Recent Developments
- 4.6 DuPont
- 4.6.1 DuPont Company Information
- 4.6.2 DuPont Business Overview
- 4.6.3 DuPont Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 DuPont Bio Active Protein and Peptides Product Portfolio
- 4.6.5 DuPont Recent Developments
- 4.7 Fonterra Co-operative Group
- 4.7.1 Fonterra Co-operative Group Company Information
- 4.7.2 Fonterra Co-operative Group Business Overview
- 4.7.3 Fonterra Co-operative Group Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Fonterra Co-operative Group Bio Active Protein and Peptides Product Portfolio
- 4.7.5 Fonterra Co-operative Group Recent Developments
- 4.8 Royal DSM
- 4.8.1 Royal DSM Company Information
- 4.8.2 Royal DSM Business Overview
- 4.8.3 Royal DSM Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Royal DSM Bio Active Protein and Peptides Product Portfolio
- 4.8.5 Royal DSM Recent Developments
5 Global Bio Active Protein and Peptides Market Scenario by Region
- 5.1 Global Bio Active Protein and Peptides Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bio Active Protein and Peptides Sales by Region: 2021-2032
- 5.2.1 Global Bio Active Protein and Peptides Sales by Region: 2021-2026
- 5.2.2 Global Bio Active Protein and Peptides Sales by Region: 2027-2032
- 5.3 Global Bio Active Protein and Peptides Revenue by Region: 2021-2032
- 5.3.1 Global Bio Active Protein and Peptides Revenue by Region: 2021-2026
- 5.3.2 Global Bio Active Protein and Peptides Revenue by Region: 2027-2032
- 5.4 North America Bio Active Protein and Peptides Market Facts & Figures by Country
- 5.4.1 North America Bio Active Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bio Active Protein and Peptides Sales by Country (2021-2032)
- 5.4.3 North America Bio Active Protein and Peptides Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bio Active Protein and Peptides Market Facts & Figures by Country
- 5.5.1 Europe Bio Active Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bio Active Protein and Peptides Sales by Country (2021-2032)
- 5.5.3 Europe Bio Active Protein and Peptides Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bio Active Protein and Peptides Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bio Active Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bio Active Protein and Peptides Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bio Active Protein and Peptides Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bio Active Protein and Peptides Market Facts & Figures by Country
- 5.7.1 South America Bio Active Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bio Active Protein and Peptides Sales by Country (2021-2032)
- 5.7.3 South America Bio Active Protein and Peptides Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Bio Active Protein and Peptides Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bio Active Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bio Active Protein and Peptides Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bio Active Protein and Peptides Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bio Active Protein and Peptides Sales by Type (2021-2032)
- 6.1.1 Global Bio Active Protein and Peptides Sales by Type (2021-2032) & (kt)
- 6.1.2 Global Bio Active Protein and Peptides Sales Market Share by Type (2021-2032)
- 6.2 Global Bio Active Protein and Peptides Revenue by Type (2021-2032)
- 6.2.1 Global Bio Active Protein and Peptides Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bio Active Protein and Peptides Revenue Market Share by Type (2021-2032)
- 6.3 Global Bio Active Protein and Peptides Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bio Active Protein and Peptides Sales by Application (2021-2032)
- 7.1.1 Global Bio Active Protein and Peptides Sales by Application (2021-2032) & (kt)
- 7.1.2 Global Bio Active Protein and Peptides Sales Market Share by Application (2021-2032)
- 7.2 Global Bio Active Protein and Peptides Revenue by Application (2021-2032)
- 7.2.1 Global Bio Active Protein and Peptides Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bio Active Protein and Peptides Revenue Market Share by Application (2021-2032)
- 7.3 Global Bio Active Protein and Peptides Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bio Active Protein and Peptides Value Chain Analysis
- 8.1.1 Bio Active Protein and Peptides Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bio Active Protein and Peptides Production Mode & Process
- 8.2 Bio Active Protein and Peptides Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bio Active Protein and Peptides Distributors
- 8.2.3 Bio Active Protein and Peptides Customers
9 Global Bio Active Protein and Peptides Analyzing Market Dynamics
- 9.1 Bio Active Protein and Peptides Industry Trends
- 9.2 Bio Active Protein and Peptides Industry Drivers
- 9.3 Bio Active Protein and Peptides Industry Opportunities and Challenges
- 9.4 Bio Active Protein and Peptides Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst